TAZVERIK
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for TAZVERIK, covering 2020-01-23 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment [Phase 1]